![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bittar RE, da Fonseca EB, de Carvalho MHB, Martinelli S, Zugaib M. 2007. Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin-like growth factor-binding protein-1. Ultrasound in Obstetrics and Gynecology 29:562–567.
- Iams JD, Casal D, McGregor JA, Goodwin MT, Kreaden US, Lowensohn R . 1995. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. American Journal of Obstetrics and Gynecology 173:141–145.
- Maria Paternoster D, Muresan D, Vitulo A, Serena A, Battagliarin G, Dell'Avanzo M . 2007. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstetricia et Gynecologica Scandinavica 86:151–155.
- Rahkonen L, Rutanen E, Nuutila M, Sainio S, Saisto T, Paavonen J. 2010. Elevated levels of decidual insulin-like growth factor binding protein-1 in cervical fluid in early and mid-pregnancy are associated with an increased risk of spontaneous preterm delivery. British Journal of Obstetrics and Gynaecology 117:701–710.
- Rutanen EM. 2000. Insulin-like growth factors in obstetrics. Current Opinion in Obstetrics and Gynecology 12:163–168.
- Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G . 2006. General obstetrics: a randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: The PREMET Study. British Journal of Obstetrics and Gynaecology 113:65–74.
- Slattery M, Morrison J. 2002. Preterm delivery. Lancet 360:1489–1497.
- Ting H, Chin P, Yeo GSH, Kwek K. 2007. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Annals of the Academy of Medicine, Singapore 36:399–402.